Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Update

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) was the recipient of a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 469,800 shares, a decrease of 43.1% from the January 31st total of 825,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 4,698.0 days.

Recordati Industria Chimica e Farmaceutica Stock Performance

Shares of Recordati Industria Chimica e Farmaceutica stock remained flat at $55.54 during midday trading on Friday. The company has a market capitalization of $11.46 billion, a PE ratio of 27.77 and a beta of 0.30. The business’s 50 day moving average price is $55.21 and its 200 day moving average price is $53.27. Recordati Industria Chimica e Farmaceutica has a 12 month low of $52.25 and a 12 month high of $52.25.

Recordati Industria Chimica e Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.